Watch: First Data Invests in Restaurant Software Company Salido

Salido, a restaurant software startup, has raised $12 million in Series A funding, with First Data as an investor. Salido’s point-of-sale hardware and software can extract customer data for restaurants. The program details exactly what customers order, how much money they spent, and details how much time their customers spend at the table.

Restaurants will then be able to tailor decisions based on what their customers are into. Salido’s technology will be integrated into some of First Data’s Clover products, according to a statement. The announcement comes as First Data launched their own Clover Mini and Clover Flex products in Germany and Austria.

Follow us on social media for the latest updates in B2B!

Image

Latest

Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More
Firefly
Pursuing the Impossible: The New Space Race with Firefly Aerospace Co-Founder Eric Salwan
April 1, 2026

Many companies set out to do something hard. Firefly Aerospace set out to do the impossible. After 10 years and several existential moments, Firefly did what no private company ever had: in 2025, it successfully landed on the Moon. Before Firefly, only countries had ever landed on the Moon—and it took extraordinary national effort…

Read More